Global Singleplex Immunoassay Market By Offerings (Instruments, Platform); By Species (Human, Non-Human Primate, Mouse, Rat, Porcine, Canine); By Application (Drug Discovery and Development, Research and Development, Clinical diagnostics, Biomarker Discovery, Others); By Disease Type (Cardiovascular, Cancer, Infectious disease, Neurology, Inflammation, Others); By End Users (Pharmaceutical & Biotechnology Companies, Hospitals and Clinics, Research Laboratories); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031
Global Singleplex Immunoassay Market is Growing at an Estimated CAGR of 10.5% from 2023- 2031.
A singleplex immunoassay is a type of test that allows the detection and quantification of a single analyte, usually a protein, within a biological sample. It works by using specific antibodies that recognize and bind to the target analyte, and then measuring the resulting signal, such as fluorescence or color change, which indicates the presence and amount of the analyte. This type of assay is commonly used in research, drug development, and clinical diagnostics to measure the levels of specific proteins or biomarkers. Singleplex immunoassays can provide highly specific and sensitive measurements of individual analytes and are often used to monitor disease progression, evaluate treatment efficacy, and identify new drug targets.
Global Singleplex Immunoassay Market Revenue & Forecast, (US$ Million), 2015 – 2031
Species Outlook
The singleplex immunoassay market can be segmented by species in the following:
- Human: This is the largest segment of the singleplex immunoassay market, as there is a high demand for human-specific assays in clinical diagnostics and research.
- Non-Human Primate: Non-human primate assays are commonly used in preclinical research and drug development to evaluate safety and efficacy.
- Mouse: Mouse assays are widely used in research to study the molecular mechanisms of diseases and to evaluate potential drug targets.
- Rat: Rat assays are also commonly used in research, particularly in the fields of neuroscience and toxicology.
- Porcine: Porcine assays are used in veterinary medicine and in research on diseases that affect pigs.
- Canine: Canine assays are used in veterinary medicine and research on diseases that affect dogs.
Disease Type Outlook
The major contributor to the singleplex immunoassay market by disease type is cancer. The use of singleplex immunoassays in cancer research and diagnostics has grown rapidly in recent years, driven by the need for more precise and personalized treatments. Singleplex immunoassays can detect specific biomarkers associated with different types of cancer, such as PSA for prostate cancer, CA 125 for ovarian cancer, and HER2 for breast cancer. These assays provide highly sensitive and specific measurements of individual biomarkers, which can help in the early diagnosis and monitoring of cancer, as well as in the development of new cancer therapies.
In addition to cancer, infectious diseases are also a significant contributor to the singleplex immunoassay market. The COVID-19 pandemic has further accelerated the demand for singleplex immunoassays for the detection of specific antigens or antibodies in blood or other biological fluids.
Region Outlook
The increasing focus on personalized medicine is driving the demand for singleplex immunoassay market in North America. The high prevalence of chronic diseases in North America, such as cardiovascular diseases, cancer, and diabetes, is driving the demand for singleplex immunoassays for disease diagnosis and monitoring. North America is an early adopter of advanced technologies, including singleplex immunoassays, which is driving the growth of the market in the region. The development of new technologies, such as digital immunoassays and microfluidics, is also contributing to the growth of the market. Furthermore, major players in the singleplex immunoassay market in North America are increasingly forming strategic partnerships and collaborations to expand their product portfolios and reach new customers. This trend is expected to continue to drive the growth of the market in the region.
Competitive Landscape
The report provides both, qualitative and quantitative research of global singleplex immunoassay market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the key players operating in the global singleplex immunoassay market are listed below:
- Abcam plc
- Agilent Technologies
- BD
- Bio-Rad Laboratories, Inc.
- Bio-Techne
- BioVendor R&D
- BioXpedia A/S
- Creative Biolabs
- Merck KGaA
- QIAGEN
- Quanterix
- Thermo Fisher Scientific
- Other Industry Participants
Global Singleplex Immunoassay Market:
By Offerings
- Instruments
- Platform
By Species
- Human
- Non-Human Primate
- Mouse
- Rat
- Porcine
- Canine
By Application
- Drug Discovery and Development
- Research and Development
- Clinical diagnostics
- Biomarker Discovery
- Others
By Disease Type
- Cardiovascular
- Cancer
- Infectious disease
- Neurology
- Inflammation
- Others
By End Users
- Pharmaceutical & Biotechnology Companies
- Hospitals and clinics
- Research Laboratories
By Region
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2021
1.2.2. Base
Year: 2022
1.2.3. Forecast
Years: 2023 – 2031
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Singleplex Immunoassay Market
6. Market Synopsis:
Singleplex Immunoassay Market
7. Singleplex Immunoassay Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Singleplex Immunoassay Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Singleplex Immunoassay Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Singleplex Immunoassay Market
8. Global Singleplex Immunoassay Market Analysis and Forecasts,
2023 – 2031
8.1. Overview
8.1.1. Global
Singleplex Immunoassay Market Revenue (US$ Mn)
8.2. Global
Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By Offerings
8.2.1. Instruments
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2022
8.2.1.3. Market Forecast, 2023 - 2031
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2022
8.2.1.5.1.2. Market
Forecast, 2023 - 2031
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2022
8.2.1.5.2.2. Market
Forecast, 2023 - 2031
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2022
8.2.1.5.3.2. Market
Forecast, 2023 - 2031
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2022
8.2.1.5.4.2. Market
Forecast, 2023 - 2031
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2022
8.2.1.5.5.2. Market
Forecast, 2023 - 2031
8.2.2. Platform
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2022
8.2.2.3. Market Forecast, 2023 - 2031
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2022
8.2.2.5.1.2. Market
Forecast, 2023 - 2031
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2022
8.2.2.5.2.2. Market
Forecast, 2023 - 2031
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2022
8.2.2.5.3.2. Market
Forecast, 2023 - 2031
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2022
8.2.2.5.4.2. Market
Forecast, 2023 - 2031
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2022
8.2.2.5.5.2. Market
Forecast, 2023 - 2031
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offerings
9. Global Singleplex Immunoassay Market Analysis and Forecasts,
2023 – 2031
9.1. Overview
9.2. Global
Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By Species
9.2.1. Human
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2022
9.2.1.3. Market Forecast, 2023 - 2031
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2022
9.2.1.5.1.2. Market
Forecast, 2023 - 2031
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2022
9.2.1.5.2.2. Market
Forecast, 2023 - 2031
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2022
9.2.1.5.3.2. Market
Forecast, 2023 - 2031
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2022
9.2.1.5.4.2. Market
Forecast, 2023 - 2031
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2022
9.2.1.5.5.2. Market
Forecast, 2023 - 2031
9.2.2. Non-Human
Primate
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2022
9.2.2.3. Market Forecast, 2023 - 2031
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2022
9.2.2.5.1.2. Market
Forecast, 2023 - 2031
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2022
9.2.2.5.2.2. Market
Forecast, 2023 - 2031
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2022
9.2.2.5.3.2. Market
Forecast, 2023 - 2031
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2022
9.2.2.5.4.2. Market
Forecast, 2023 - 2031
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2022
9.2.2.5.5.2. Market
Forecast, 2023 - 2031
9.2.3. Mouse
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2022
9.2.3.3. Market Forecast, 2023 - 2031
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2022
9.2.3.5.1.2. Market
Forecast, 2023 - 2031
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2022
9.2.3.5.2.2. Market
Forecast, 2023 - 2031
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2022
9.2.3.5.3.2. Market
Forecast, 2023 - 2031
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2022
9.2.3.5.4.2. Market
Forecast, 2023 - 2031
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2022
9.2.3.5.5.2. Market
Forecast, 2023 - 2031
9.2.4. Rat
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2022
9.2.4.3. Market Forecast, 2023 - 2031
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 - 2022
9.2.4.5.1.2. Market
Forecast, 2023 - 2031
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2022
9.2.4.5.2.2. Market
Forecast, 2023 - 2031
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2022
9.2.4.5.3.2. Market
Forecast, 2023 - 2031
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2022
9.2.4.5.4.2. Market
Forecast, 2023 - 2031
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 - 2022
9.2.4.5.5.2. Market
Forecast, 2023 - 2031
9.2.5. Porcine
9.2.5.1. Definition
9.2.5.2. Market Estimation and Penetration, 2015 - 2022
9.2.5.3. Market Forecast, 2023 - 2031
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1. Market
Estimation, 2015 - 2022
9.2.5.5.1.2. Market
Forecast, 2023 - 2031
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2022
9.2.5.5.2.2. Market
Forecast, 2023 - 2031
9.2.5.5.3. Asia Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2022
9.2.5.5.3.2. Market
Forecast, 2023 - 2031
9.2.5.5.4. Middle East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2022
9.2.5.5.4.2. Market
Forecast, 2023 - 2031
9.2.5.5.5. Latin America
9.2.5.5.5.1. Market
Estimation, 2015 - 2022
9.2.5.5.5.2. Market
Forecast, 2023 - 2031
9.2.6. Canine
9.2.6.1. Definition
9.2.6.2. Market Estimation and Penetration, 2015 - 2022
9.2.6.3. Market Forecast, 2023 - 2031
9.2.6.4. Compound Annual Growth Rate (CAGR)
9.2.6.5. Regional Bifurcation
9.2.6.5.1. North America
9.2.6.5.1.1. Market
Estimation, 2015 - 2022
9.2.6.5.1.2. Market
Forecast, 2023 - 2031
9.2.6.5.2. Europe
9.2.6.5.2.1. Market
Estimation, 2015 - 2022
9.2.6.5.2.2. Market
Forecast, 2023 - 2031
9.2.6.5.3. Asia Pacific
9.2.6.5.3.1. Market
Estimation, 2015 - 2022
9.2.6.5.3.2. Market
Forecast, 2023 - 2031
9.2.6.5.4. Middle East and Africa
9.2.6.5.4.1. Market
Estimation, 2015 - 2022
9.2.6.5.4.2. Market
Forecast, 2023 - 2031
9.2.6.5.5. Latin America
9.2.6.5.5.1. Market
Estimation, 2015 - 2022
9.2.6.5.5.2. Market
Forecast, 2023 - 2031
9.3. Key
Segment for Channeling Investments
9.3.1. By
Species
10. Global Singleplex Immunoassay Market Analysis and Forecasts,
2023 – 2031
10.1. Overview
10.2. Global
Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By Application
10.2.1. Drug
Discovery and Development
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2022
10.2.1.3. Market Forecast, 2023 - 2031
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2022
10.2.1.5.1.2. Market
Forecast, 2023 - 2031
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2022
10.2.1.5.2.2. Market
Forecast, 2023 - 2031
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2022
10.2.1.5.3.2. Market
Forecast, 2023 - 2031
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2022
10.2.1.5.4.2. Market
Forecast, 2023 - 2031
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2022
10.2.1.5.5.2. Market
Forecast, 2023 - 2031
10.2.2. Research
and Development
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2022
10.2.2.3. Market Forecast, 2023 - 2031
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2022
10.2.2.5.1.2. Market
Forecast, 2023 - 2031
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2022
10.2.2.5.2.2. Market
Forecast, 2023 - 2031
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2022
10.2.2.5.3.2. Market
Forecast, 2023 - 2031
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2022
10.2.2.5.4.2. Market
Forecast, 2023 - 2031
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2022
10.2.2.5.5.2. Market
Forecast, 2023 - 2031
10.2.3. Clinical
diagnostics
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2022
10.2.3.3. Market Forecast, 2023 - 2031
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2022
10.2.3.5.1.2. Market
Forecast, 2023 - 2031
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2022
10.2.3.5.2.2. Market
Forecast, 2023 - 2031
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2022
10.2.3.5.3.2. Market
Forecast, 2023 - 2031
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2022
10.2.3.5.4.2. Market
Forecast, 2023 - 2031
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2022
10.2.3.5.5.2. Market
Forecast, 2023 - 2031
10.2.4. Biomarker
Discovery
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2022
10.2.4.3. Market Forecast, 2023 - 2031
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2022
10.2.4.5.1.2. Market
Forecast, 2023 - 2031
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2022
10.2.4.5.2.2. Market
Forecast, 2023 - 2031
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2022
10.2.4.5.3.2. Market
Forecast, 2023 - 2031
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2022
10.2.4.5.4.2. Market
Forecast, 2023 - 2031
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2022
10.2.4.5.5.2. Market
Forecast, 2023 - 2031
10.2.5. Others
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 - 2022
10.2.5.3. Market Forecast, 2023 - 2031
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market
Estimation, 2015 - 2022
10.2.5.5.1.2. Market
Forecast, 2023 - 2031
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 - 2022
10.2.5.5.2.2. Market
Forecast, 2023 - 2031
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market
Estimation, 2015 - 2022
10.2.5.5.3.2. Market
Forecast, 2023 - 2031
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 - 2022
10.2.5.5.4.2. Market
Forecast, 2023 - 2031
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market
Estimation, 2015 - 2022
10.2.5.5.5.2. Market
Forecast, 2023 - 2031
10.3. Key
Segment for Channeling Investments
10.3.1. By
Application
11. Global Singleplex Immunoassay Market Analysis and Forecasts,
2023 – 2031
11.1. Overview
11.2. Global
Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By Disease Type
11.2.1. Cardiovascular
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2022
11.2.1.3. Market Forecast, 2023 - 2031
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2022
11.2.1.5.1.2. Market
Forecast, 2023 - 2031
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2022
11.2.1.5.2.2. Market
Forecast, 2023 - 2031
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2022
11.2.1.5.3.2. Market
Forecast, 2023 - 2031
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2022
11.2.1.5.4.2. Market
Forecast, 2023 - 2031
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2022
11.2.1.5.5.2. Market
Forecast, 2023 - 2031
11.2.2. Cancer
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2022
11.2.2.3. Market Forecast, 2023 - 2031
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2022
11.2.2.5.1.2. Market
Forecast, 2023 - 2031
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2022
11.2.2.5.2.2. Market
Forecast, 2023 - 2031
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2022
11.2.2.5.3.2. Market
Forecast, 2023 - 2031
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2022
11.2.2.5.4.2. Market
Forecast, 2023 - 2031
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2022
11.2.2.5.5.2. Market
Forecast, 2023 - 2031
11.2.3. Infectious
disease
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2022
11.2.3.3. Market Forecast, 2023 - 2031
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2022
11.2.3.5.1.2. Market
Forecast, 2023 - 2031
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2022
11.2.3.5.2.2. Market
Forecast, 2023 - 2031
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2022
11.2.3.5.3.2. Market
Forecast, 2023 - 2031
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2022
11.2.3.5.4.2. Market
Forecast, 2023 - 2031
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2022
11.2.3.5.5.2. Market
Forecast, 2023 - 2031
11.2.4. Neurology
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 - 2022
11.2.4.3. Market Forecast, 2023 - 2031
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market
Estimation, 2015 - 2022
11.2.4.5.1.2. Market
Forecast, 2023 - 2031
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 - 2022
11.2.4.5.2.2. Market
Forecast, 2023 - 2031
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market
Estimation, 2015 - 2022
11.2.4.5.3.2. Market
Forecast, 2023 - 2031
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 - 2022
11.2.4.5.4.2. Market
Forecast, 2023 - 2031
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market
Estimation, 2015 - 2022
11.2.4.5.5.2. Market
Forecast, 2023 - 2031
11.2.5. Inflammation
11.2.5.1. Definition
11.2.5.2. Market Estimation and Penetration, 2015 - 2022
11.2.5.3. Market Forecast, 2023 - 2031
11.2.5.4. Compound Annual Growth Rate (CAGR)
11.2.5.5. Regional Bifurcation
11.2.5.5.1. North America
11.2.5.5.1.1. Market
Estimation, 2015 - 2022
11.2.5.5.1.2. Market
Forecast, 2023 - 2031
11.2.5.5.2. Europe
11.2.5.5.2.1. Market
Estimation, 2015 - 2022
11.2.5.5.2.2. Market
Forecast, 2023 - 2031
11.2.5.5.3. Asia Pacific
11.2.5.5.3.1. Market
Estimation, 2015 - 2022
11.2.5.5.3.2. Market
Forecast, 2023 - 2031
11.2.5.5.4. Middle East and Africa
11.2.5.5.4.1. Market
Estimation, 2015 - 2022
11.2.5.5.4.2. Market
Forecast, 2023 - 2031
11.2.5.5.5. Latin America
11.2.5.5.5.1. Market
Estimation, 2015 - 2022
11.2.5.5.5.2. Market
Forecast, 2023 - 2031
11.2.6. Others
11.2.6.1. Definition
11.2.6.2. Market Estimation and Penetration, 2015 - 2022
11.2.6.3. Market Forecast, 2023 - 2031
11.2.6.4. Compound Annual Growth Rate (CAGR)
11.2.6.5. Regional Bifurcation
11.2.6.5.1. North America
11.2.6.5.1.1. Market
Estimation, 2015 - 2022
11.2.6.5.1.2. Market
Forecast, 2023 - 2031
11.2.6.5.2. Europe
11.2.6.5.2.1. Market
Estimation, 2015 - 2022
11.2.6.5.2.2. Market
Forecast, 2023 - 2031
11.2.6.5.3. Asia Pacific
11.2.6.5.3.1. Market
Estimation, 2015 - 2022
11.2.6.5.3.2. Market
Forecast, 2023 - 2031
11.2.6.5.4. Middle East and Africa
11.2.6.5.4.1. Market
Estimation, 2015 - 2022
11.2.6.5.4.2. Market
Forecast, 2023 - 2031
11.2.6.5.5. Latin America
11.2.6.5.5.1. Market
Estimation, 2015 - 2022
11.2.6.5.5.2. Market
Forecast, 2023 - 2031
11.3. Key
Segment for Channeling Investments
11.3.1. By
Disease Type
12. Global Singleplex Immunoassay Market Analysis and Forecasts,
2023 – 2031
12.1. Overview
12.2. Global
Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By End Users
12.2.1. Pharmaceutical
and Biotechnology Companies
12.2.1.1. Definition
12.2.1.2. Market Estimation and Penetration, 2015 - 2022
12.2.1.3. Market Forecast, 2023 - 2031
12.2.1.4. Compound Annual Growth Rate (CAGR)
12.2.1.5. Regional Bifurcation
12.2.1.5.1. North America
12.2.1.5.1.1. Market
Estimation, 2015 - 2022
12.2.1.5.1.2. Market
Forecast, 2023 - 2031
12.2.1.5.2. Europe
12.2.1.5.2.1. Market
Estimation, 2015 - 2022
12.2.1.5.2.2. Market
Forecast, 2023 - 2031
12.2.1.5.3. Asia Pacific
12.2.1.5.3.1. Market
Estimation, 2015 - 2022
12.2.1.5.3.2. Market
Forecast, 2023 - 2031
12.2.1.5.4. Middle East and Africa
12.2.1.5.4.1. Market
Estimation, 2015 - 2022
12.2.1.5.4.2. Market
Forecast, 2023 - 2031
12.2.1.5.5. Latin America
12.2.1.5.5.1. Market
Estimation, 2015 - 2022
12.2.1.5.5.2. Market
Forecast, 2023 - 2031
12.2.2. Hospitals and clinics
12.2.2.1. Definition
12.2.2.2. Market Estimation and Penetration, 2015 - 2022
12.2.2.3. Market Forecast, 2023 - 2031
12.2.2.4. Compound Annual Growth Rate (CAGR)
12.2.2.5. Regional Bifurcation
12.2.2.5.1. North America
12.2.2.5.1.1. Market
Estimation, 2015 - 2022
12.2.2.5.1.2. Market
Forecast, 2023 - 2031
12.2.2.5.2. Europe
12.2.2.5.2.1. Market
Estimation, 2015 - 2022
12.2.2.5.2.2. Market
Forecast, 2023 - 2031
12.2.2.5.3. Asia Pacific
12.2.2.5.3.1. Market
Estimation, 2015 - 2022
12.2.2.5.3.2. Market
Forecast, 2023 - 2031
12.2.2.5.4. Middle East and Africa
12.2.2.5.4.1. Market
Estimation, 2015 - 2022
12.2.2.5.4.2. Market
Forecast, 2023 - 2031
12.2.2.5.5. Latin America
12.2.2.5.5.1. Market
Estimation, 2015 - 2022
12.2.2.5.5.2. Market
Forecast, 2023 - 2031
12.2.3. Research Laboratories
12.2.3.1. Definition
12.2.3.2. Market Estimation and Penetration, 2015 - 2022
12.2.3.3. Market Forecast, 2023 - 2031
12.2.3.4. Compound Annual Growth Rate (CAGR)
12.2.3.5. Regional Bifurcation
12.2.3.5.1. North America
12.2.3.5.1.1. Market
Estimation, 2015 - 2022
12.2.3.5.1.2. Market
Forecast, 2023 - 2031
12.2.3.5.2. Europe
12.2.3.5.2.1. Market
Estimation, 2015 - 2022
12.2.3.5.2.2. Market
Forecast, 2023 - 2031
12.2.3.5.3. Asia Pacific
12.2.3.5.3.1. Market
Estimation, 2015 - 2022
12.2.3.5.3.2. Market
Forecast, 2023 - 2031
12.2.3.5.4. Middle East and Africa
12.2.3.5.4.1. Market
Estimation, 2015 - 2022
12.2.3.5.4.2. Market
Forecast, 2023 - 2031
12.2.3.5.5. Latin America
12.2.3.5.5.1. Market
Estimation, 2015 - 2022
12.2.3.5.5.2. Market
Forecast, 2023 - 2031
12.3. Key
Segment for Channeling Investments
12.3.1. By End
Users
13. North America Singleplex Immunoassay Market Analysis and
Forecasts, 2023 - 2031
13.1. Overview
13.1.1. North
America Singleplex Immunoassay Market Revenue (US$ Mn)
13.2. North
America Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Offerings
13.2.1. Instruments
13.2.2. Platform
13.3. North
America Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Species
13.3.1. Human
13.3.2. Non-Human
Primate
13.3.3. Mouse
13.3.4. Rat
13.3.5. Porcine
13.3.6. Canine
13.4. North
America Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Application
13.4.1. Drug
Discovery and Development
13.4.2. Research
and Development
13.4.3. Clinical
diagnostics
13.4.4. Biomarker
Discovery
13.4.5. Others
13.5. North
America Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Disease Type
13.5.1. Cardiovascular
13.5.2. Cancer
13.5.3. Infectious
disease
13.5.4. Neurology
13.5.5. Inflammation
13.5.6. Others
13.6. North
America Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By End
Users
13.6.1. Pharmaceutical
and Biotechnology Companies
13.6.2. Hospitals and clinics
13.6.3. Research Laboratories
13.7. North
America Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Country
13.7.1. U.S
13.7.1.1. U.S Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.7.1.1.1. Instruments
13.7.1.1.2. Platform
13.7.1.2. U.S Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
13.7.1.2.1. Human
13.7.1.2.2. Non-Human Primate
13.7.1.2.3. Mouse
13.7.1.2.4. Rat
13.7.1.2.5. Porcine
13.7.1.2.6. Canine
13.7.1.3. U.S Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
13.7.1.3.1. Drug Discovery and Development
13.7.1.3.2. Research and Development
13.7.1.3.3. Clinical diagnostics
13.7.1.3.4. Biomarker Discovery
13.7.1.3.5. Others
13.7.1.4. U.S Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
13.7.1.4.1. Cardiovascular
13.7.1.4.2. Cancer
13.7.1.4.3. Infectious disease
13.7.1.4.4. Neurology
13.7.1.4.5. Inflammation
13.7.1.4.6. Others
13.7.1.5. U.S Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
13.7.1.5.1. Pharmaceutical and Biotechnology Companies
13.7.1.5.2. Hospitals and clinics
13.7.1.5.3. Research Laboratories
13.7.2. Canada
13.7.2.1. Canada Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.7.2.1.1. Instruments
13.7.2.1.2. Platform
13.7.2.2. Canada Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
13.7.2.2.1. Human
13.7.2.2.2. Non-Human Primate
13.7.2.2.3. Mouse
13.7.2.2.4. Rat
13.7.2.2.5. Porcine
13.7.2.2.6. Canine
13.7.2.3. Canada Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
13.7.2.3.1. Drug Discovery and Development
13.7.2.3.2. Research and Development
13.7.2.3.3. Clinical diagnostics
13.7.2.3.4. Biomarker Discovery
13.7.2.3.5. Others
13.7.2.4. Canada Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
13.7.2.4.1. Cardiovascular
13.7.2.4.2. Cancer
13.7.2.4.3. Infectious disease
13.7.2.4.4. Neurology
13.7.2.4.5. Inflammation
13.7.2.4.6. Others
13.7.2.5. Canada Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
13.7.2.5.1. Pharmaceutical and Biotechnology Companies
13.7.2.5.2. Hospitals and clinics
13.7.2.5.3. Research Laboratories
13.7.3. Mexico
13.7.3.1. Mexico Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.7.3.1.1. Instruments
13.7.3.1.2. Platform
13.7.3.2. Mexico Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
13.7.3.2.1. Human
13.7.3.2.2. Non-Human Primate
13.7.3.2.3. Mouse
13.7.3.2.4. Rat
13.7.3.2.5. Porcine
13.7.3.2.6. Canine
13.7.3.3. Mexico Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
13.7.3.3.1. Drug Discovery and Development
13.7.3.3.2. Research and Development
13.7.3.3.3. Clinical diagnostics
13.7.3.3.4. Biomarker Discovery
13.7.3.3.5. Others
13.7.3.4. Mexico Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
13.7.3.4.1. Cardiovascular
13.7.3.4.2. Cancer
13.7.3.4.3. Infectious disease
13.7.3.4.4. Neurology
13.7.3.4.5. Inflammation
13.7.3.4.6. Others
13.7.3.5. Mexico Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
13.7.3.5.1. Pharmaceutical and Biotechnology Companies
13.7.3.5.2. Hospitals and clinics
13.7.3.5.3. Research Laboratories
13.7.4. Rest of
North America
13.7.4.1. Rest of North America Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By Offerings
13.7.4.1.1. Instruments
13.7.4.1.2. Platform
13.7.4.2. Rest of North America Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By Species
13.7.4.2.1. Human
13.7.4.2.2. Non-Human Primate
13.7.4.2.3. Mouse
13.7.4.2.4. Rat
13.7.4.2.5. Porcine
13.7.4.2.6. Canine
13.7.4.3. Rest of North America Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By Application
13.7.4.3.1. Drug Discovery and Development
13.7.4.3.2. Research and Development
13.7.4.3.3. Clinical diagnostics
13.7.4.3.4. Biomarker Discovery
13.7.4.3.5. Others
13.7.4.4. Rest of North America Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By Disease Type
13.7.4.4.1. Cardiovascular
13.7.4.4.2. Cancer
13.7.4.4.3. Infectious disease
13.7.4.4.4. Neurology
13.7.4.4.5. Inflammation
13.7.4.4.6. Others
13.7.4.5. Rest of North America Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By End Users
13.7.4.5.1. Pharmaceutical and Biotechnology Companies
13.7.4.5.2. Hospitals and clinics
13.7.4.5.3. Research Laboratories
13.8. Key
Segment for Channeling Investments
13.8.1. By
Country
13.8.2. By
Offerings
13.8.3. By
Species
13.8.4. By
Application
13.8.5. By
Disease Type
13.8.6. By End
Users
14. Europe Singleplex Immunoassay Market Analysis and Forecasts,
2023 - 2031
14.1. Overview
14.1.1. Europe
Singleplex Immunoassay Market Revenue (US$ Mn)
14.2. Europe
Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By Offerings
14.2.1. Instruments
14.2.2. Platform
14.3. Europe
Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By Species
14.3.1. Human
14.3.2. Non-Human
Primate
14.3.3. Mouse
14.3.4. Rat
14.3.5. Porcine
14.3.6. Canine
14.4. Europe
Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By Application
14.4.1. Drug
Discovery and Development
14.4.2. Research
and Development
14.4.3. Clinical
diagnostics
14.4.4. Biomarker
Discovery
14.4.5. Others
14.5. Europe
Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By Disease Type
14.5.1. Cardiovascular
14.5.2. Cancer
14.5.3. Infectious
disease
14.5.4. Neurology
14.5.5. Inflammation
14.5.6. Others
14.6. Europe
Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.1. Pharmaceutical
and Biotechnology Companies
14.6.2. Hospitals and clinics
14.6.3. Research Laboratories
14.7. Europe
Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By Country
14.7.1. France
14.7.1.1. France Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.7.1.1.1. Instruments
14.7.1.1.2. Platform
14.7.1.2. France Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
14.7.1.2.1. Human
14.7.1.2.2. Non-Human Primate
14.7.1.2.3. Mouse
14.7.1.2.4. Rat
14.7.1.2.5. Porcine
14.7.1.2.6. Canine
14.7.1.3. France Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.1.3.1. Drug Discovery and Development
14.7.1.3.2. Research and Development
14.7.1.3.3. Clinical diagnostics
14.7.1.3.4. Biomarker Discovery
14.7.1.3.5. Others
14.7.1.4. France Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
14.7.1.4.1. Cardiovascular
14.7.1.4.2. Cancer
14.7.1.4.3. Infectious disease
14.7.1.4.4. Neurology
14.7.1.4.5. Inflammation
14.7.1.4.6. Others
14.7.1.5. France Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.1.5.1. Pharmaceutical and Biotechnology Companies
14.7.1.5.2. Hospitals and clinics
14.7.1.5.3. Research Laboratories
14.7.2. The UK
14.7.2.1. The UK Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.7.2.1.1. Instruments
14.7.2.1.2. Platform
14.7.2.2. The UK Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
14.7.2.2.1. Human
14.7.2.2.2. Non-Human Primate
14.7.2.2.3. Mouse
14.7.2.2.4. Rat
14.7.2.2.5. Porcine
14.7.2.2.6. Canine
14.7.2.3. The UK Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.2.3.1. Drug Discovery and Development
14.7.2.3.2. Research and Development
14.7.2.3.3. Clinical diagnostics
14.7.2.3.4. Biomarker Discovery
14.7.2.3.5. Others
14.7.2.4. The UK Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
14.7.2.4.1. Cardiovascular
14.7.2.4.2. Cancer
14.7.2.4.3. Infectious disease
14.7.2.4.4. Neurology
14.7.2.4.5. Inflammation
14.7.2.4.6. Others
14.7.2.5. The UK Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.2.5.1. Pharmaceutical and Biotechnology Companies
14.7.2.5.2. Hospitals and clinics
14.7.2.5.3. Research Laboratories
14.7.3. Spain
14.7.3.1. Spain Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.7.3.1.1. Instruments
14.7.3.1.2. Platform
14.7.3.2. Spain Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
14.7.3.2.1. Human
14.7.3.2.2. Non-Human Primate
14.7.3.2.3. Mouse
14.7.3.2.4. Rat
14.7.3.2.5. Porcine
14.7.3.2.6. Canine
14.7.3.3. Spain Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.3.3.1. Drug Discovery and Development
14.7.3.3.2. Research and Development
14.7.3.3.3. Clinical diagnostics
14.7.3.3.4. Biomarker Discovery
14.7.3.3.5. Others
14.7.3.4. Spain Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
14.7.3.4.1. Cardiovascular
14.7.3.4.2. Cancer
14.7.3.4.3. Infectious disease
14.7.3.4.4. Neurology
14.7.3.4.5. Inflammation
14.7.3.4.6. Others
14.7.3.5. Spain Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.3.5.1. Pharmaceutical and Biotechnology Companies
14.7.3.5.2. Hospitals and clinics
14.7.3.5.3. Research Laboratories
14.7.4. Germany
14.7.4.1. Germany Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.7.4.1.1. Instruments
14.7.4.1.2. Platform
14.7.4.2. Germany Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
14.7.4.2.1. Human
14.7.4.2.2. Non-Human Primate
14.7.4.2.3. Mouse
14.7.4.2.4. Rat
14.7.4.2.5. Porcine
14.7.4.2.6. Canine
14.7.4.3. Germany Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.4.3.1. Drug Discovery and Development
14.7.4.3.2. Research and Development
14.7.4.3.3. Clinical diagnostics
14.7.4.3.4. Biomarker Discovery
14.7.4.3.5. Others
14.7.4.4. Germany Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
14.7.4.4.1. Cardiovascular
14.7.4.4.2. Cancer
14.7.4.4.3. Infectious disease
14.7.4.4.4. Neurology
14.7.4.4.5. Inflammation
14.7.4.4.6. Others
14.7.4.5. Germany Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.4.5.1. Pharmaceutical and Biotechnology Companies
14.7.4.5.2. Hospitals and clinics
14.7.4.5.3. Research Laboratories
14.7.5. Italy
14.7.5.1. Italy Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.7.5.1.1. Instruments
14.7.5.1.2. Platform
14.7.5.2. Italy Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
14.7.5.2.1. Human
14.7.5.2.2. Non-Human Primate
14.7.5.2.3. Mouse
14.7.5.2.4. Rat
14.7.5.2.5. Porcine
14.7.5.2.6. Canine
14.7.5.3. Italy Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
14.7.5.3.1. Drug Discovery and Development
14.7.5.3.2. Research and Development
14.7.5.3.3. Clinical diagnostics
14.7.5.3.4. Biomarker Discovery
14.7.5.3.5. Others
14.7.5.4. Italy Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
14.7.5.4.1. Cardiovascular
14.7.5.4.2. Cancer
14.7.5.4.3. Infectious disease
14.7.5.4.4. Neurology
14.7.5.4.5. Inflammation
14.7.5.4.6. Others
14.7.5.5. Italy Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
14.7.5.5.1. Pharmaceutical and Biotechnology Companies
14.7.5.5.2. Hospitals and clinics
14.7.5.5.3. Research Laboratories
14.7.6. Nordic
Countries
14.7.6.1. Nordic Countries Singleplex Immunoassay Market Revenue (US$
Mn) and Forecasts, By Offerings
14.7.6.1.1. Instruments
14.7.6.1.2. Platform
14.7.6.2. Nordic Countries Singleplex Immunoassay Market Revenue (US$
Mn) and Forecasts, By Species
14.7.6.2.1. Human
14.7.6.2.2. Non-Human Primate
14.7.6.2.3. Mouse
14.7.6.2.4. Rat
14.7.6.2.5. Porcine
14.7.6.2.6. Canine
14.7.6.3. Nordic Countries Singleplex Immunoassay Market Revenue (US$
Mn) and Forecasts, By Application
14.7.6.3.1. Drug Discovery and Development
14.7.6.3.2. Research and Development
14.7.6.3.3. Clinical diagnostics
14.7.6.3.4. Biomarker Discovery
14.7.6.3.5. Others
14.7.6.4. Nordic Countries Singleplex Immunoassay Market Revenue (US$
Mn) and Forecasts, By Disease Type
14.7.6.4.1. Cardiovascular
14.7.6.4.2. Cancer
14.7.6.4.3. Infectious disease
14.7.6.4.4. Neurology
14.7.6.4.5. Inflammation
14.7.6.4.6. Others
14.7.6.5. Nordic Countries Singleplex Immunoassay Market Revenue (US$
Mn) and Forecasts, By End Users
14.7.6.5.1. Pharmaceutical and Biotechnology Companies
14.7.6.5.2. Hospitals and clinics
14.7.6.5.3. Research Laboratories
14.7.6.6. Nordic Countries Singleplex Immunoassay Market Revenue (US$
Mn) and Forecasts, By Country
14.7.6.6.1. Denmark
14.7.6.6.2. Finland
14.7.6.6.3. Iceland
14.7.6.6.4. Sweden
14.7.6.6.5. Norway
14.7.7. Benelux
Union
14.7.7.1. Benelux Union Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Offerings
14.7.7.1.1. Instruments
14.7.7.1.2. Platform
14.7.7.2. Benelux Union Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Species
14.7.7.2.1. Human
14.7.7.2.2. Non-Human Primate
14.7.7.2.3. Mouse
14.7.7.2.4. Rat
14.7.7.2.5. Porcine
14.7.7.2.6. Canine
14.7.7.3. Benelux Union Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Application
14.7.7.3.1. Drug Discovery and Development
14.7.7.3.2. Research and Development
14.7.7.3.3. Clinical diagnostics
14.7.7.3.4. Biomarker Discovery
14.7.7.3.5. Others
14.7.7.4. Benelux Union Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Disease Type
14.7.7.4.1. Cardiovascular
14.7.7.4.2. Cancer
14.7.7.4.3. Infectious disease
14.7.7.4.4. Neurology
14.7.7.4.5. Inflammation
14.7.7.4.6. Others
14.7.7.5. Benelux Union Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By End Users
14.7.7.5.1. Pharmaceutical and Biotechnology Companies
14.7.7.5.2. Hospitals and clinics
14.7.7.5.3. Research Laboratories
14.7.7.6. Benelux Union Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Country
14.7.7.6.1. Belgium
14.7.7.6.2. The Netherlands
14.7.7.6.3. Luxembourg
14.7.8. Rest of
Europe
14.7.8.1. Rest of Europe Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Offerings
14.7.8.1.1. Instruments
14.7.8.1.2. Platform
14.7.8.2. Rest of Europe Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Species
14.7.8.2.1. Human
14.7.8.2.2. Non-Human Primate
14.7.8.2.3. Mouse
14.7.8.2.4. Rat
14.7.8.2.5. Porcine
14.7.8.2.6. Canine
14.7.8.3. Rest of Europe Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Application
14.7.8.3.1. Drug Discovery and Development
14.7.8.3.2. Research and Development
14.7.8.3.3. Clinical diagnostics
14.7.8.3.4. Biomarker Discovery
14.7.8.3.5. Others
14.7.8.4. Rest of Europe Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Disease Type
14.7.8.4.1. Cardiovascular
14.7.8.4.2. Cancer
14.7.8.4.3. Infectious disease
14.7.8.4.4. Neurology
14.7.8.4.5. Inflammation
14.7.8.4.6. Others
14.7.8.5. Rest of Europe Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By End Users
14.7.8.5.1. Pharmaceutical and Biotechnology Companies
14.7.8.5.2. Hospitals and clinics
14.7.8.5.3. Research Laboratories
14.8. Key
Segment for Channeling Investments
14.8.1. By
Country
14.8.2. By
Offerings
14.8.3. By
Species
14.8.4. By
Application
14.8.5. By
Disease Type
14.8.6. By End
Users
15. Asia Pacific Singleplex Immunoassay Market Analysis and
Forecasts, 2023 - 2031
15.1. Overview
15.1.1. Asia Pacific
Singleplex Immunoassay Market Revenue (US$ Mn)
15.2. Asia
Pacific Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Offerings
15.2.1. Instruments
15.2.2. Platform
15.3. Asia
Pacific Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Species
15.3.1. Human
15.3.2. Non-Human
Primate
15.3.3. Mouse
15.3.4. Rat
15.3.5. Porcine
15.3.6. Canine
15.4. Asia
Pacific Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Application
15.4.1. Drug
Discovery and Development
15.4.2. Research
and Development
15.4.3. Clinical
diagnostics
15.4.4. Biomarker
Discovery
15.4.5. Others
15.5. Asia
Pacific Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Disease Type
15.5.1. Cardiovascular
15.5.2. Cancer
15.5.3. Infectious
disease
15.5.4. Neurology
15.5.5. Inflammation
15.5.6. Others
15.6. Asia
Pacific Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By End
Users
15.6.1. Pharmaceutical
and Biotechnology Companies
15.6.2. Hospitals and clinics
15.6.3. Research Laboratories
15.7. Asia
Pacific Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Country
15.7.1. China
15.7.1.1. China Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.7.1.1.1. Instruments
15.7.1.1.2. Platform
15.7.1.2. China Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
15.7.1.2.1. Human
15.7.1.2.2. Non-Human Primate
15.7.1.2.3. Mouse
15.7.1.2.4. Rat
15.7.1.2.5. Porcine
15.7.1.2.6. Canine
15.7.1.3. China Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.1.3.1. Drug Discovery and Development
15.7.1.3.2. Research and Development
15.7.1.3.3. Clinical diagnostics
15.7.1.3.4. Biomarker Discovery
15.7.1.3.5. Others
15.7.1.4. China Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
15.7.1.4.1. Cardiovascular
15.7.1.4.2. Cancer
15.7.1.4.3. Infectious disease
15.7.1.4.4. Neurology
15.7.1.4.5. Inflammation
15.7.1.4.6. Others
15.7.1.5. China Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.1.5.1. Pharmaceutical and Biotechnology Companies
15.7.1.5.2. Hospitals and clinics
15.7.1.5.3. Research Laboratories
15.7.2. Japan
15.7.2.1. Japan Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.7.2.1.1. Instruments
15.7.2.1.2. Platform
15.7.2.2. Japan Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
15.7.2.2.1. Human
15.7.2.2.2. Non-Human Primate
15.7.2.2.3. Mouse
15.7.2.2.4. Rat
15.7.2.2.5. Porcine
15.7.2.2.6. Canine
15.7.2.3. Japan Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.2.3.1. Drug Discovery and Development
15.7.2.3.2. Research and Development
15.7.2.3.3. Clinical diagnostics
15.7.2.3.4. Biomarker Discovery
15.7.2.3.5. Others
15.7.2.4. Japan Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
15.7.2.4.1. Cardiovascular
15.7.2.4.2. Cancer
15.7.2.4.3. Infectious disease
15.7.2.4.4. Neurology
15.7.2.4.5. Inflammation
15.7.2.4.6. Others
15.7.2.5. Japan Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.2.5.1. Pharmaceutical and Biotechnology Companies
15.7.2.5.2. Hospitals and clinics
15.7.2.5.3. Research Laboratories
15.7.3. India
15.7.3.1. India Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.7.3.1.1. Instruments
15.7.3.1.2. Platform
15.7.3.2. India Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
15.7.3.2.1. Human
15.7.3.2.2. Non-Human Primate
15.7.3.2.3. Mouse
15.7.3.2.4. Rat
15.7.3.2.5. Porcine
15.7.3.2.6. Canine
15.7.3.3. India Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.3.3.1. Drug Discovery and Development
15.7.3.3.2. Research and Development
15.7.3.3.3. Clinical diagnostics
15.7.3.3.4. Biomarker Discovery
15.7.3.3.5. Others
15.7.3.4. India Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
15.7.3.4.1. Cardiovascular
15.7.3.4.2. Cancer
15.7.3.4.3. Infectious disease
15.7.3.4.4. Neurology
15.7.3.4.5. Inflammation
15.7.3.4.6. Others
15.7.3.5. India Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.3.5.1. Pharmaceutical and Biotechnology Companies
15.7.3.5.2. Hospitals and clinics
15.7.3.5.3. Research Laboratories
15.7.4. New
Zealand
15.7.4.1. New Zealand Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.7.4.1.1. Instruments
15.7.4.1.2. Platform
15.7.4.2. New Zealand Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
15.7.4.2.1. Human
15.7.4.2.2. Non-Human Primate
15.7.4.2.3. Mouse
15.7.4.2.4. Rat
15.7.4.2.5. Porcine
15.7.4.2.6. Canine
15.7.4.3. New Zealand Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.4.3.1. Drug Discovery and Development
15.7.4.3.2. Research and Development
15.7.4.3.3. Clinical diagnostics
15.7.4.3.4. Biomarker Discovery
15.7.4.3.5. Others
15.7.4.4. New Zealand Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
15.7.4.4.1. Cardiovascular
15.7.4.4.2. Cancer
15.7.4.4.3. Infectious disease
15.7.4.4.4. Neurology
15.7.4.4.5. Inflammation
15.7.4.4.6. Others
15.7.4.5. New Zealand Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.4.5.1. Pharmaceutical and Biotechnology Companies
15.7.4.5.2. Hospitals and clinics
15.7.4.5.3. Research Laboratories
15.7.5. Australia
15.7.5.1. Australia Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.7.5.1.1. Instruments
15.7.5.1.2. Platform
15.7.5.2. Australia Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
15.7.5.2.1. Human
15.7.5.2.2. Non-Human Primate
15.7.5.2.3. Mouse
15.7.5.2.4. Rat
15.7.5.2.5. Porcine
15.7.5.2.6. Canine
15.7.5.3. Australia Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.5.3.1. Drug Discovery and Development
15.7.5.3.2. Research and Development
15.7.5.3.3. Clinical diagnostics
15.7.5.3.4. Biomarker Discovery
15.7.5.3.5. Others
15.7.5.4. Australia Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
15.7.5.4.1. Cardiovascular
15.7.5.4.2. Cancer
15.7.5.4.3. Infectious disease
15.7.5.4.4. Neurology
15.7.5.4.5. Inflammation
15.7.5.4.6. Others
15.7.5.5. Australia Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.5.5.1. Pharmaceutical and Biotechnology Companies
15.7.5.5.2. Hospitals and clinics
15.7.5.5.3. Research Laboratories
15.7.6. South
Korea
15.7.6.1. South Korea Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.7.6.1.1. Instruments
15.7.6.1.2. Platform
15.7.6.2. South Korea Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
15.7.6.2.1. Human
15.7.6.2.2. Non-Human Primate
15.7.6.2.3. Mouse
15.7.6.2.4. Rat
15.7.6.2.5. Porcine
15.7.6.2.6. Canine
15.7.6.3. South Korea Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
15.7.6.3.1. Drug Discovery and Development
15.7.6.3.2. Research and Development
15.7.6.3.3. Clinical diagnostics
15.7.6.3.4. Biomarker Discovery
15.7.6.3.5. Others
15.7.6.4. South Korea Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
15.7.6.4.1. Cardiovascular
15.7.6.4.2. Cancer
15.7.6.4.3. Infectious disease
15.7.6.4.4. Neurology
15.7.6.4.5. Inflammation
15.7.6.4.6. Others
15.7.6.5. South Korea Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
15.7.6.5.1. Pharmaceutical and Biotechnology Companies
15.7.6.5.2. Hospitals and clinics
15.7.6.5.3. Research Laboratories
15.7.7. Southeast
Asia
15.7.7.1. Southeast Asia Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Offerings
15.7.7.1.1. Instruments
15.7.7.1.2. Platform
15.7.7.2. Southeast Asia Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Species
15.7.7.2.1. Human
15.7.7.2.2. Non-Human Primate
15.7.7.2.3. Mouse
15.7.7.2.4. Rat
15.7.7.2.5. Porcine
15.7.7.2.6. Canine
15.7.7.3. Southeast Asia Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Application
15.7.7.3.1. Drug Discovery and Development
15.7.7.3.2. Research and Development
15.7.7.3.3. Clinical diagnostics
15.7.7.3.4. Biomarker Discovery
15.7.7.3.5. Others
15.7.7.4. Southeast Asia Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Disease Type
15.7.7.4.1. Cardiovascular
15.7.7.4.2. Cancer
15.7.7.4.3. Infectious disease
15.7.7.4.4. Neurology
15.7.7.4.5. Inflammation
15.7.7.4.6. Others
15.7.7.5. Southeast Asia Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By End Users
15.7.7.5.1. Pharmaceutical and Biotechnology Companies
15.7.7.5.2. Hospitals and clinics
15.7.7.5.3. Research Laboratories
15.7.7.6. Southeast Asia Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Country
15.7.7.6.1. Indonesia
15.7.7.6.2. Thailand
15.7.7.6.3. Malaysia
15.7.7.6.4. Singapore
15.7.7.6.5. Rest of Southeast Asia
15.7.8. Rest of
Asia Pacific
15.7.8.1. Rest of Asia Pacific Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By Offerings
15.7.8.1.1. Instruments
15.7.8.1.2. Platform
15.7.8.2. Rest of Asia Pacific Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By Species
15.7.8.2.1. Human
15.7.8.2.2. Non-Human Primate
15.7.8.2.3. Mouse
15.7.8.2.4. Rat
15.7.8.2.5. Porcine
15.7.8.2.6. Canine
15.7.8.3. Rest of Asia Pacific Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By Application
15.7.8.3.1. Drug Discovery and Development
15.7.8.3.2. Research and Development
15.7.8.3.3. Clinical diagnostics
15.7.8.3.4. Biomarker Discovery
15.7.8.3.5. Others
15.7.8.4. Rest of Asia Pacific Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By Disease Type
15.7.8.4.1. Cardiovascular
15.7.8.4.2. Cancer
15.7.8.4.3. Infectious disease
15.7.8.4.4. Neurology
15.7.8.4.5. Inflammation
15.7.8.4.6. Others
15.7.8.5. Rest of Asia Pacific Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By End Users
15.7.8.5.1. Pharmaceutical and Biotechnology Companies
15.7.8.5.2. Hospitals and clinics
15.7.8.5.3. Research Laboratories
15.8. Key
Segment for Channeling Investments
15.8.1. By Country
15.8.2. By
Offerings
15.8.3. By
Species
15.8.4. By
Application
15.8.5. By
Disease Type
15.8.6. By End
Users
16. Middle East and Africa Singleplex Immunoassay Market Analysis
and Forecasts, 2023 - 2031
16.1. Overview
16.1.1. Middle
East and Africa Singleplex Immunoassay Market Revenue (US$ Mn)
16.2. Middle East
and Africa Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Offerings
16.2.1. Instruments
16.2.2. Platform
16.3. Middle
East and Africa Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts,
By Species
16.3.1. Human
16.3.2. Non-Human
Primate
16.3.3. Mouse
16.3.4. Rat
16.3.5. Porcine
16.3.6. Canine
16.4. Middle
East and Africa Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts,
By Application
16.4.1. Drug
Discovery and Development
16.4.2. Research
and Development
16.4.3. Clinical
diagnostics
16.4.4. Biomarker
Discovery
16.4.5. Others
16.5. Middle
East and Africa Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts,
By Disease Type
16.5.1. Cardiovascular
16.5.2. Cancer
16.5.3. Infectious
disease
16.5.4. Neurology
16.5.5. Inflammation
16.5.6. Others
16.6. Middle
East and Africa Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts,
By End Users
16.6.1. Pharmaceutical
and Biotechnology Companies
16.6.2. Hospitals and clinics
16.6.3. Research Laboratories
16.7. Middle
East and Africa Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts,
By Country
16.7.1. Saudi
Arabia
16.7.1.1. Saudi Arabia Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Offerings
16.7.1.1.1. Instruments
16.7.1.1.2. Platform
16.7.1.2. Saudi Arabia Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Species
16.7.1.2.1. Human
16.7.1.2.2. Non-Human Primate
16.7.1.2.3. Mouse
16.7.1.2.4. Rat
16.7.1.2.5. Porcine
16.7.1.2.6. Canine
16.7.1.3. Saudi Arabia Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Application
16.7.1.3.1. Drug Discovery and Development
16.7.1.3.2. Research and Development
16.7.1.3.3. Clinical diagnostics
16.7.1.3.4. Biomarker Discovery
16.7.1.3.5. Others
16.7.1.4. Saudi Arabia Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Disease Type
16.7.1.4.1. Cardiovascular
16.7.1.4.2. Cancer
16.7.1.4.3. Infectious disease
16.7.1.4.4. Neurology
16.7.1.4.5. Inflammation
16.7.1.4.6. Others
16.7.1.5. Saudi Arabia Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By End Users
16.7.1.5.1. Pharmaceutical and Biotechnology Companies
16.7.1.5.2. Hospitals and clinics
16.7.1.5.3. Research Laboratories
16.7.2. UAE
16.7.2.1. UAE Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
16.7.2.1.1. Instruments
16.7.2.1.2. Platform
16.7.2.2. UAE Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
16.7.2.2.1. Human
16.7.2.2.2. Non-Human Primate
16.7.2.2.3. Mouse
16.7.2.2.4. Rat
16.7.2.2.5. Porcine
16.7.2.2.6. Canine
16.7.2.3. UAE Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.2.3.1. Drug Discovery and Development
16.7.2.3.2. Research and Development
16.7.2.3.3. Clinical diagnostics
16.7.2.3.4. Biomarker Discovery
16.7.2.3.5. Others
16.7.2.4. UAE Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
16.7.2.4.1. Cardiovascular
16.7.2.4.2. Cancer
16.7.2.4.3. Infectious disease
16.7.2.4.4. Neurology
16.7.2.4.5. Inflammation
16.7.2.4.6. Others
16.7.2.5. UAE Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
16.7.2.5.1. Pharmaceutical and Biotechnology Companies
16.7.2.5.2. Hospitals and clinics
16.7.2.5.3. Research Laboratories
16.7.3. Egypt
16.7.3.1. Egypt Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
16.7.3.1.1. Instruments
16.7.3.1.2. Platform
16.7.3.2. Egypt Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
16.7.3.2.1. Human
16.7.3.2.2. Non-Human Primate
16.7.3.2.3. Mouse
16.7.3.2.4. Rat
16.7.3.2.5. Porcine
16.7.3.2.6. Canine
16.7.3.3. Egypt Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.3.3.1. Drug Discovery and Development
16.7.3.3.2. Research and Development
16.7.3.3.3. Clinical diagnostics
16.7.3.3.4. Biomarker Discovery
16.7.3.3.5. Others
16.7.3.4. Egypt Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
16.7.3.4.1. Cardiovascular
16.7.3.4.2. Cancer
16.7.3.4.3. Infectious disease
16.7.3.4.4. Neurology
16.7.3.4.5. Inflammation
16.7.3.4.6. Others
16.7.3.5. Egypt Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
16.7.3.5.1. Pharmaceutical and Biotechnology Companies
16.7.3.5.2. Hospitals and clinics
16.7.3.5.3. Research Laboratories
16.7.4. Kuwait
16.7.4.1. Kuwait Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
16.7.4.1.1. Instruments
16.7.4.1.2. Platform
16.7.4.2. Kuwait Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
16.7.4.2.1. Human
16.7.4.2.2. Non-Human Primate
16.7.4.2.3. Mouse
16.7.4.2.4. Rat
16.7.4.2.5. Porcine
16.7.4.2.6. Canine
16.7.4.3. Kuwait Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
16.7.4.3.1. Drug Discovery and Development
16.7.4.3.2. Research and Development
16.7.4.3.3. Clinical diagnostics
16.7.4.3.4. Biomarker Discovery
16.7.4.3.5. Others
16.7.4.4. Kuwait Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
16.7.4.4.1. Cardiovascular
16.7.4.4.2. Cancer
16.7.4.4.3. Infectious disease
16.7.4.4.4. Neurology
16.7.4.4.5. Inflammation
16.7.4.4.6. Others
16.7.4.5. Kuwait Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
16.7.4.5.1. Pharmaceutical and Biotechnology Companies
16.7.4.5.2. Hospitals and clinics
16.7.4.5.3. Research Laboratories
16.7.5. South
Africa
16.7.5.1. South Africa Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Offerings
16.7.5.1.1. Instruments
16.7.5.1.2. Platform
16.7.5.2. South Africa Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Species
16.7.5.2.1. Human
16.7.5.2.2. Non-Human Primate
16.7.5.2.3. Mouse
16.7.5.2.4. Rat
16.7.5.2.5. Porcine
16.7.5.2.6. Canine
16.7.5.3. South Africa Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Application
16.7.5.3.1. Drug Discovery and Development
16.7.5.3.2. Research and Development
16.7.5.3.3. Clinical diagnostics
16.7.5.3.4. Biomarker Discovery
16.7.5.3.5. Others
16.7.5.4. South Africa Singleplex Immunoassay Market Revenue (US$ Mn)
and Forecasts, By Disease Type
16.7.5.4.1. Cardiovascular
16.7.5.4.2. Cancer
16.7.5.4.3. Infectious disease
16.7.5.4.4. Neurology
16.7.5.4.5. Inflammation
16.7.5.4.6. Others
16.7.5.5. South Africa Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
16.7.5.5.1. Pharmaceutical and Biotechnology Companies
16.7.5.5.2. Hospitals and clinics
16.7.5.5.3. Research Laboratories
16.7.6. Rest of
Middle East & Africa
16.7.6.1. Rest of Middle East & Africa Singleplex Immunoassay Market
Revenue (US$ Mn) and Forecasts, By Offerings
16.7.6.1.1. Instruments
16.7.6.1.2. Platform
16.7.6.2. Rest of Middle East & Africa Singleplex Immunoassay Market
Revenue (US$ Mn) and Forecasts, By Species
16.7.6.2.1. Human
16.7.6.2.2. Non-Human Primate
16.7.6.2.3. Mouse
16.7.6.2.4. Rat
16.7.6.2.5. Porcine
16.7.6.2.6. Canine
16.7.6.3. Rest of Middle East & Africa Singleplex Immunoassay Market
Revenue (US$ Mn) and Forecasts, By Application
16.7.6.3.1. Drug Discovery and Development
16.7.6.3.2. Research and Development
16.7.6.3.3. Clinical diagnostics
16.7.6.3.4. Biomarker Discovery
16.7.6.3.5. Others
16.7.6.4. Rest of Middle East & Africa Singleplex Immunoassay Market
Revenue (US$ Mn) and Forecasts, By Disease Type
16.7.6.4.1. Cardiovascular
16.7.6.4.2. Cancer
16.7.6.4.3. Infectious disease
16.7.6.4.4. Neurology
16.7.6.4.5. Inflammation
16.7.6.4.6. Others
16.7.6.5. Rest of Middle East & Africa Singleplex Immunoassay Market
Revenue (US$ Mn) and Forecasts, By End Users
16.7.6.5.1. Pharmaceutical and Biotechnology Companies
16.7.6.5.2. Hospitals and clinics
16.7.6.5.3. Research Laboratories
16.8. Key
Segment for Channeling Investments
16.8.1. By
Country
16.8.2. By
Offerings
16.8.3. By
Species
16.8.4. By
Application
16.8.5. By
Disease Type
16.8.6. By End
Users
17. Latin America Singleplex Immunoassay Market Analysis and
Forecasts, 2023 - 2031
17.1. Overview
17.1.1. Latin
America Singleplex Immunoassay Market Revenue (US$ Mn)
17.2. Latin
America Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Offerings
17.2.1. Instruments
17.2.2. Platform
17.3. Latin
America Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Species
17.3.1. Human
17.3.2. Non-Human
Primate
17.3.3. Mouse
17.3.4. Rat
17.3.5. Porcine
17.3.6. Canine
17.4. Latin
America Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Application
17.4.1. Drug
Discovery and Development
17.4.2. Research
and Development
17.4.3. Clinical
diagnostics
17.4.4. Biomarker
Discovery
17.4.5. Others
17.5. Latin
America Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Disease Type
17.5.1. Cardiovascular
17.5.2. Cancer
17.5.3. Infectious
disease
17.5.4. Neurology
17.5.5. Inflammation
17.5.6. Others
17.6. Latin
America Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By End
Users
17.6.1. Pharmaceutical
and Biotechnology Companies
17.6.2. Hospitals and clinics
17.6.3. Research Laboratories
17.7. Latin
America Singleplex Immunoassay Market Revenue (US$ Mn) and Forecasts, By
Country
17.7.1. Brazil
17.7.1.1. Brazil Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
17.7.1.1.1. Instruments
17.7.1.1.2. Platform
17.7.1.2. Brazil Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
17.7.1.2.1. Human
17.7.1.2.2. Non-Human Primate
17.7.1.2.3. Mouse
17.7.1.2.4. Rat
17.7.1.2.5. Porcine
17.7.1.2.6. Canine
17.7.1.3. Brazil Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
17.7.1.3.1. Drug Discovery and Development
17.7.1.3.2. Research and Development
17.7.1.3.3. Clinical diagnostics
17.7.1.3.4. Biomarker Discovery
17.7.1.3.5. Others
17.7.1.4. Brazil Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
17.7.1.4.1. Cardiovascular
17.7.1.4.2. Cancer
17.7.1.4.3. Infectious disease
17.7.1.4.4. Neurology
17.7.1.4.5. Inflammation
17.7.1.4.6. Others
17.7.1.5. Brazil Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
17.7.1.5.1. Pharmaceutical and Biotechnology Companies
17.7.1.5.2. Hospitals and clinics
17.7.1.5.3. Research Laboratories
17.7.2. Argentina
17.7.2.1. Argentina Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Offerings
17.7.2.1.1. Instruments
17.7.2.1.2. Platform
17.7.2.2. Argentina Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Species
17.7.2.2.1. Human
17.7.2.2.2. Non-Human Primate
17.7.2.2.3. Mouse
17.7.2.2.4. Rat
17.7.2.2.5. Porcine
17.7.2.2.6. Canine
17.7.2.3. Argentina Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Application
17.7.2.3.1. Drug Discovery and Development
17.7.2.3.2. Research and Development
17.7.2.3.3. Clinical diagnostics
17.7.2.3.4. Biomarker Discovery
17.7.2.3.5. Others
17.7.2.4. Argentina Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By Disease Type
17.7.2.4.1. Cardiovascular
17.7.2.4.2. Cancer
17.7.2.4.3. Infectious disease
17.7.2.4.4. Neurology
17.7.2.4.5. Inflammation
17.7.2.4.6. Others
17.7.2.5. Argentina Singleplex Immunoassay Market Revenue (US$ Mn) and
Forecasts, By End Users
17.7.2.5.1. Pharmaceutical and Biotechnology Companies
17.7.2.5.2. Hospitals and clinics
17.7.2.5.3. Research Laboratories
17.7.3. Rest of
Latin America
17.7.3.1. Rest of Latin America Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By Offerings
17.7.3.1.1. Instruments
17.7.3.1.2. Platform
17.7.3.2. Rest of Latin America Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By Species
17.7.3.2.1. Human
17.7.3.2.2. Non-Human Primate
17.7.3.2.3. Mouse
17.7.3.2.4. Rat
17.7.3.2.5. Porcine
17.7.3.2.6. Canine
17.7.3.3. Rest of Latin America Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By Application
17.7.3.3.1. Drug Discovery and Development
17.7.3.3.2. Research and Development
17.7.3.3.3. Clinical diagnostics
17.7.3.3.4. Biomarker Discovery
17.7.3.3.5. Others
17.7.3.4. Rest of Latin America Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By Disease Type
17.7.3.4.1. Cardiovascular
17.7.3.4.2. Cancer
17.7.3.4.3. Infectious disease
17.7.3.4.4. Neurology
17.7.3.4.5. Inflammation
17.7.3.4.6. Others
17.7.3.5. Rest of Latin America Singleplex Immunoassay Market Revenue
(US$ Mn) and Forecasts, By End Users
17.7.3.5.1. Pharmaceutical and Biotechnology Companies
17.7.3.5.2. Hospitals and clinics
17.7.3.5.3. Research Laboratories
17.8. Key
Segment for Channeling Investments
17.8.1. By
Country
17.8.2. By
Offerings
17.8.3. By
Species
17.8.4. By
Application
17.8.5. By
Disease Type
17.8.6. By End
Users
18. Competitive Benchmarking
18.1. Market
Share Analysis, 2022
18.2. Global
Presence and Growth Strategies
18.2.1. Mergers
and Acquisitions
18.2.2. Product
Launches
18.2.3. Investments
Trends
18.2.4. R&D
Initiatives
19. Player Profiles
19.1. Abcam plc
19.1.1. Company
Details
19.1.2. Company
Overview
19.1.3. Product
Offerings
19.1.4. Key
Developments
19.1.5. Financial
Analysis
19.1.6. SWOT
Analysis
19.1.7. Business
Strategies
19.2. Agilent
Technologies
19.2.1. Company
Details
19.2.2. Company
Overview
19.2.3. Product
Offerings
19.2.4. Key
Developments
19.2.5. Financial
Analysis
19.2.6. SWOT
Analysis
19.2.7. Business
Strategies
19.3. BD
19.3.1. Company
Details
19.3.2. Company
Overview
19.3.3. Product
Offerings
19.3.4. Key
Developments
19.3.5. Financial
Analysis
19.3.6. SWOT
Analysis
19.3.7. Business
Strategies
19.4. Bio-Rad
Laboratories, Inc.
19.4.1. Company
Details
19.4.2. Company
Overview
19.4.3. Product
Offerings
19.4.4. Key
Developments
19.4.5. Financial
Analysis
19.4.6. SWOT
Analysis
19.4.7. Business
Strategies
19.5. Bio-Techne
19.5.1. Company
Details
19.5.2. Company
Overview
19.5.3. Product
Offerings
19.5.4. Key
Developments
19.5.5. Financial
Analysis
19.5.6. SWOT
Analysis
19.5.7. Business
Strategies
19.6. BioVendor
R&D
19.6.1. Company
Details
19.6.2. Company
Overview
19.6.3. Product
Offerings
19.6.4. Key
Developments
19.6.5. Financial
Analysis
19.6.6. SWOT
Analysis
19.6.7. Business
Strategies
19.7. BioXpedia
A/S
19.7.1. Company
Details
19.7.2. Company
Overview
19.7.3. Product
Offerings
19.7.4. Key
Developments
19.7.5. Financial
Analysis
19.7.6. SWOT
Analysis
19.7.7. Business
Strategies
19.8. Creative
Biolabs
19.8.1. Company
Details
19.8.2. Company
Overview
19.8.3. Product
Offerings
19.8.4. Key
Developments
19.8.5. Financial
Analysis
19.8.6. SWOT
Analysis
19.8.7. Business
Strategies
19.9. Merck
KGaA
19.9.1. Company
Details
19.9.2. Company
Overview
19.9.3. Product
Offerings
19.9.4. Key
Developments
19.9.5. Financial
Analysis
19.9.6. SWOT
Analysis
19.9.7. Business
Strategies
19.10. QIAGEN
19.10.1. Company
Details
19.10.2. Company
Overview
19.10.3. Product
Offerings
19.10.4. Key
Developments
19.10.5. Financial
Analysis
19.10.6. SWOT
Analysis
19.10.7. Business
Strategies
19.11. Quanterix
19.11.1. Company
Details
19.11.2. Company
Overview
19.11.3. Product
Offerings
19.11.4. Key
Developments
19.11.5. Financial
Analysis
19.11.6. SWOT
Analysis
19.11.7. Business
Strategies
19.12. Thermo
Fisher Scientific
19.12.1. Company
Details
19.12.2. Company
Overview
19.12.3. Product
Offerings
19.12.4. Key
Developments
19.12.5. Financial
Analysis
19.12.6. SWOT
Analysis
19.12.7. Business Strategies
19.13. Other
Market Participants
20. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User
and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.